10 Stocks to Buy Too Cheap to Pass Up in 2024
Published: 2024-04-26
Status:
Analyzed
Published: 2024-04-26
Status:
Analyzed
Predictions from this Video
Incorrect: 0
Prediction
Topic
Status
IGT shares have a potential return of 26% (low target) to 46% (high target) based on analyst forecasts.
"look at the analyst forecast with even the low Target at 26% higher and the high Target for 46% potential return"
Pending
AMN Healthcare shares have a potential return of 22% (low target) to 33% (average target, reaching $76) based on analyst consensus.
"even the low price Target here is for 22% higher while the average would be a 33% return to $76 a share"
Pending
Newmont Corporation shares have a potential upside of up to 43% based on analysts' top price target.
"analysts believe the stock can go higher still as much as 43% higher to a top price Target among 13 analysts"
Pending
Warner Brothers Discovery's revenue is expected to increase after the current quarter, driven by the return of better movie productions post-strike.
"as the better movies come back we should see Revenue increase after this quarter"
Pending
Warner Brothers Discovery shares have an average potential upside of 50%, with a high estimate of 135% higher to $20 per share, based on analyst estimates.
"valuation multiple Improvement could be closer to analyst estimates for a 50% upside on average and as high as 135% higher to $20 a share"
Pending
Walgreens Boots Alliance is expected to use nearly $7 billion from asset sales to pay down its $30 billion long-term debt.
"Nearly $7 billion in proceeds from the boot sale along with other sources are going to help it pay down that long-term debt of $30 billion"
Pending
Walgreens Boots Alliance is positioning itself for a sale of the entire company or a leveraged buyout by cutting costs and selling non-core assets.
"This is a company cutting its cost selling non-core assets and setting itself up for a sale of the entire company or to take itself private in a leveraged buyout"
Pending
Walgreens Boots Alliance shares have a potential return of 10% (low target) to 104% (high target) based on analyst forecasts.
"even the low Target is for a 10% pop in the shares with a high Target among 13 analysts for 104% return"
Pending
Genpact's revenue is expected to keep growing due to demand from the AI revolution.
"AI Revolution which should help keep revenue growing on the demand for that trend"
Pending
Genpact's revenue is expected to increase by 3% this year and 6% next year, potentially reversing its recent stock slide.
"revenue is expected up just 3% this year but 6% next year which should help it turn around that recent slide"
Pending
Genpact shares have a potential upside of 20% (average target) to 36% (high target) based on analyst forecasts.
"even the lowest analyst Target a positive return the average of nine surveyed analysts is for 20% upside while the high would be 36% higher"
Pending
Improved hospital profitability, driven by higher medical costs and increased procedures, could lead to better cash flow for Medical Properties Trust.
"with health insurance stocks falling on higher medical costs and increased procedures we could see improved Hospital profitability slow down to that better cash flow for medical real estate owners like mpw"
Pending
Medical Properties Trust's Funds From Operations (FFO) are expected to decrease by only 2% this year, a significant improvement from last year's drop.
"funds from operation or ffo are expected lower by just 2% this year that is a big improvement over the drop last year"
Pending
Medical Properties Trust shares could return to $10 each if revalued to six or seven times its FFO.
"even a revaluation to maybe six or seven times ffo would take this stock back to $10 each"
Pending
Medical Properties Trust is predicted to surprise the market over the next year, paying down its debt and seeing its shares go much higher.
"I think this one surprises the market over the next year paying down its debt and going much higher"
Pending
WW International is expected to report surprisingly strong subscription numbers next week, potentially surprising the market.
"early estimates are for subscriptions that are way over forecast and the market could get a surprise when the company reports next week"
Pending
WW International shares have a potential upside, with an average analyst target of 228% higher and a high target of almost 600% higher.
"analysts see the potential here with an average Target that is 228% higher and a high that is almost 600% from here"
Pending
Alibaba Group Holdings is expected to spin off its cloud and logistics units into IPOs to unlock shareholder value.
"The company has already discussed spin-off of assets into IPOs to unlock some of this value including the cloud and Logistics units"
Pending
Alibaba Group Holdings shares have a potential return, with the low analyst target above the current price and the high target at an 86% return.
"even the low analyst Target is above the current price and the high Target would be an 86% return from here"
Pending
ChargePoint's subscription revenue is a hidden catalyst that is expected to drive overall revenue even higher.
"there is a hidden Catalyst here that is taking Revenue even higher and that is subscription Revenue which grew by 40% annual Pace last quarter"
Pending
ChargePoint's subscription and support revenue is expected to continue growing due to high customer stickiness after purchasing charging equipment.
"that subscription and support revenue is going to continue to grow because customers are extremely sticky here for the company once they buy that charging equipment that subscription revenue is locked in"
Pending
ChargePoint shares could see a 100% return if its price-to-revenue multiple increases to two times.
"even a pop to two times Revenue would be a 100% return"
Pending
ChargePoint shares have a potential return of 10% (low target) to 340% (high target) based on analyst forecasts.
"The low analyst Target here is for 10% higher and the high Target is for 340% return"
Pending
US healthcare system estimated to be short 124,000 doctors by 2034.
"The company estimates will be short 124,000 doctors by 2034"
Pending